IV etanercept or GDNF are not neuroprotective in experimental stroke because these biologics do not cross the BBB, and because the BBB is intact in the early hours after stroke [758,759], when neuroprotection in stroke is possible [756,757]. Here, GDNF is linked to stroke disorder.